Camille Kim

Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds.

Piul S. Rabbani, J. Thomson, D. Ceradini, 2018, Diabetes research and clinical practice.

Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing.

Piul S. Rabbani, Joseph A. Frezzo, J. Montclare, 2017, Biomaterials.

Nrf2-activating Therapy Accelerates Wound Healing in a Model of Cutaneous Chronic Venous Insufficiency

Piul S. Rabbani, D. Ceradini, J. Kwong, 2020, Plastic and reconstructive surgery. Global open.

Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing.

Piul S. Rabbani, Joseph A. Frezzo, J. Montclare, 2017, Biomaterials.